Beijing Genome Institute and PentaBase Strengthen their Collaboration
Complete the form below to unlock access to ALL audio articles.
Chinese Beijing Genome Institute, BGI, has announced that it has increased its collaboration with PentaBase, Denmark. Following a successful first benchmark of PentaBase’s technologies against competing technologies, BGI (together with Danish BGI partner SD Genomics) and PentaBase have now strengthened their collaboration with the aim to co-develop outstanding kits for the detection of important clinical biomarkers. The kits will be based on Real-Time PCR.
With the general trend pointing towards Personalized Medicine, development of robust, sensitive and specific genetic diagnostics is essential. BGI, SD Genomics and PentaBase want to launch a range of ground breaking diagnostic assays. It is a perfect fit between two parties with complementary knowledge and technology. "We have magnificent perspectives in creating a win-win situation,” says Ulf B. Christensen, CEO, PentaBase.
